LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 23 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
2,916,468 |
2.26% |
464,657 |
0.36% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
362,656 |
0.28% |
738,524 |
0.57% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
TOTAL: |
|
|
|
|
|
3,279,124 |
2.54% |
1,203,181 |
0.93% |
||
|
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities |
Price per unit |
Purchase | 34 |
209.2950 USD |
Purchase | 35 |
210.5600 USD |
Purchase | 100 |
207.8900 USD |
Purchase | 100 |
209.6000 USD |
Purchase | 100 |
209.5400 USD |
Purchase | 172 |
209.3306 USD |
Purchase | 200 |
209.7600 USD |
Purchase | 275 |
208.6118 USD |
Purchase | 360 |
209.6802 USD |
Purchase | 372 |
209.1310 USD |
Purchase | 605 |
209.6979 USD |
Purchase | 693 |
209.5645 USD |
Purchase | 982 |
209.6012 USD |
Purchase | 1,814 |
209.1536 USD |
Purchase | 2,174 |
209.3051 USD |
Purchase | 2,192 |
208.6739 USD |
Purchase | 2,316 |
209.6450 USD |
Purchase | 3,038 |
209.3815 USD |
Purchase | 3,147 |
209.7931 USD |
Purchase | 3,400 |
209.4080 USD |
Purchase | 4,345 |
209.7297 USD |
Purchase | 4,754 |
209.2242 USD |
Purchase | 5,746 |
209.4136 USD |
Purchase | 5,847 |
209.5168 USD |
Purchase | 7,506 |
209.6281 USD |
Purchase | 9,105 |
209.7500 USD |
Purchase | 13,200 |
208.2827 USD |
Purchase | 58,668 |
209.6144 USD |
Sale | 6 |
209.7100 USD |
Sale | 10 |
209.2400 USD |
Sale | 35 |
210.5600 USD |
Sale | 100 |
208.0100 USD |
Sale | 100 |
209.8300 USD |
Sale | 100 |
209.3500 USD |
Sale | 100 |
209.3450 USD |
Sale | 100 |
209.6900 USD |
Sale | 100 |
208.5400 USD |
Sale | 100 |
208.2200 USD |
Sale | 100 |
208.1100 USD |
Sale | 120 |
208.1350 USD |
Sale | 172 |
209.7160 USD |
Sale | 178 |
208.0207 USD |
Sale | 200 |
207.9900 USD |
Sale | 201 |
209.5587 USD |
Sale | 220 |
209.6671 USD |
Sale | 315 |
209.0601 USD |
Sale | 400 |
208.0875 USD |
Sale | 422 |
208.8525 USD |
Sale | 475 |
209.3200 USD |
Sale | 550 |
209.7366 USD |
Sale | 605 |
209.6979 USD |
Sale | 624 |
209.7323 USD |
Sale | 757 |
209.5832 USD |
Sale | 994 |
209.4061 USD |
Sale | 1,002 |
209.6201 USD |
Sale | 1,076 |
209.6873 USD |
Sale | 1,843 |
209.7500 USD |
Sale | 1,890 |
209.6181 USD |
Sale | 2,064 |
208.5655 USD |
Sale | 2,100 |
208.2414 USD |
Sale | 2,802 |
208.2281 USD |
Sale | 3,071 |
209.6550 USD |
Sale | 3,742 |
209.2666 USD |
Sale | 4,078 |
209.1369 USD |
Sale | 4,393 |
209.3416 USD |
Sale | 5,865 |
209.5922 USD |
Sale | 6,600 |
208.2827 USD |
Sale | 7,954 |
209.7244 USD |
Sale | 8,044 |
209.7133 USD |
Sale | 13,309 |
209.5588 USD |
Sale | 25,029 |
209.5839 USD |
Sale | 29,334 |
209.6144 USD |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction |
Number of relevant securities |
Price per |
|
|
unit |
|
SWAP | Short |
25,000 |
209.6138 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 26 Oct 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |